United States Cancer Biomarkers Market Share

Statistics for the 2023 & 2024 United States Cancer Biomarkers market share, created by Mordor Intelligence™ Industry Reports. United States Cancer Biomarkers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of United States Cancer Biomarkers Industry

The United States cancer biomarkers market is highly competitive and consists of a few major players. Some of the companies which are currently dominating the market are Abbott Laboratories Inc., Agilent Technologies, Biomerieux, F. Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., and Thermo Fisher Scientific, among others, hold substantial shares in the market.

US Cancer Biomarkers Market Leaders

  1. Abbott Laboratories Inc.

  2. Thermo Fisher Scientific

  3. Biomerieux

  4. Illumina Inc.

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

Abbott Laboratories Inc., Thermo Fisher Scientific, Biomerieux, Illumina Inc., F. Hoffmann-La Roche Ltd

United States Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)